Ohd JF - Search Results

1

Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome.

Bergqvist J, Ohd JF, Smeds J, Klaar S, Isola J, Nordgren H, Elmberger GP, Hellborg H, Bjohle J, Borg AL, Skoog L, Bergh J. Bergqvist J, et al. Among authors: ohd jf. Ann Oncol. 2007 May;18(5):845-50. doi: 10.1093/annonc/mdm059. Epub 2007 Mar 9. Ann Oncol. 2007. PMID: 17351254 Free article.

2

Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen.

Bergqvist J, Elmberger G, Ohd J, Linderholm B, Bjohle J, Hellborg H, Nordgren H, Borg AL, Skoog L, Bergh J. Bergqvist J, et al. Eur J Cancer. 2006 May;42(8):1104-12. doi: 10.1016/j.ejca.2006.01.028. Epub 2006 Apr 5. Eur J Cancer. 2006. PMID: 16603346

3

Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF.

Andersson J, Larsson L, Klaar S, Holmberg L, Nilsson J, Inganäs M, Carlsson G, Ohd J, Rudenstam CM, Gustavsson B, Bergh J. Andersson J, et al. Ann Oncol. 2005 May;16(5):743-8. doi: 10.1093/annonc/mdi150. Epub 2005 Mar 31. Ann Oncol. 2005. PMID: 15802278 Free article.

4

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study.

Hall P, Ploner A, Bjöhle J, Huang F, Lin CY, Liu ET, Miller LD, Nordgren H, Pawitan Y, Shaw P, Skoog L, Smeds J, Wedrén S, Ohd J, Bergh J. Hall P, et al. BMC Med. 2006 Jun 30;4:16. doi: 10.1186/1741-7015-4-16. BMC Med. 2006. PMID: 16813654 Free PMC article.

5

A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer.

Villman K, Ohd JF, Lidbrink E, Malmberg L, Lindh B, Blomqvist C, Nordgren H, Bergh J, Bergström D, Ahlgren J. Villman K, et al. Among authors: ohd jf. Eur J Cancer. 2007 May;43(7):1153-60. doi: 10.1016/j.ejca.2007.02.002. Epub 2007 Mar 29. Eur J Cancer. 2007. PMID: 17398088 Clinical Trial.

6

Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas.

Ohd JF, Nielsen CK, Campbell J, Landberg G, Löfberg H, Sjölander A. Ohd JF, et al. Gastroenterology. 2003 Jan;124(1):57-70. doi: 10.1053/gast.2003.50011. Gastroenterology. 2003. PMID: 12512030

7

Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment.

Szeps M, Dahlgren L, Aaltonen LM, Öhd J, Kanter-Lewenshon L, Dahlstrand H, Munck-Wikland E, Grandér D, Dalianis T. Szeps M, et al. J Gen Virol. 2005 Jun;86(Pt 6):1695-1702. doi: 10.1099/vir.0.80849-0. J Gen Virol. 2005. PMID: 15914847

8

Regulation of leukotriene-dependent induction of cyclooxygenase-2 and Bcl-2.

Wikström K, Ohd JF, Sjölander A. Wikström K, et al. Among authors: ohd jf. Biochem Biophys Res Commun. 2003 Mar 7;302(2):330-5. doi: 10.1016/s0006-291x(03)00187-6. Biochem Biophys Res Commun. 2003. PMID: 12604350

9

The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer.

Nielsen CK, Ohd JF, Wikström K, Massoumi R, Paruchuri S, Juhas M, Sjölander A. Nielsen CK, et al. Among authors: ohd jf. Adv Exp Med Biol. 2003;525:201-4. doi: 10.1007/978-1-4419-9194-2_43. Adv Exp Med Biol. 2003. PMID: 12751768 No abstract available.

10

A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells.

Nielsen CK, Campbell JI, Ohd JF, Mörgelin M, Riesbeck K, Landberg G, Sjölander A. Nielsen CK, et al. Among authors: ohd jf. Cancer Res. 2005 Feb 1;65(3):732-42. Cancer Res. 2005. PMID: 15705869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters